Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Aguettant.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Aguettant
France Flag
Country
Country
France
Address
Address
1 rue Alexander Fleming - 69007 LYON
Telephone
Telephone
+33 4 78 61 51 41

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the DZUVEO licensing agreement, Aguettant will have the right to commercialize DZUVEO in Europe. In 2018, AcelRx received approval for DZUVEO from the European Commission for use in medically monitored settings.


Lead Product(s): Sufentanil Citrate

Therapeutic Area: Neurology Product Name: Dzuveo

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: AcelRx Pharmaceuticals

Deal Size: $55.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement July 14, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY